pharmacie et médicaments – Pénurie de Repatha et Praluent en France

This written question concerns the shortage of Repatha and Praluent medications in France. It seeks information on the causes and potential solutions to ensure patient access to these treatments. Patients in France requiring Repatha and Praluent may face treatment interruptions. The question aims to address the impact on healthcare and find ways to prevent future shortages.